Lower drug sales potential at Bayer underscores need for deals
2018-12-5 03:51 pm
Germany's Bayer , which acquired seed company Monsanto this year, reduced its combined sales estimate for its most promising experimental drugs, acknowledging it needs to do more to replenish the development pipeline.
Read The Rest at
Danske investors bank on Maersk clan to chart...
OPEC works on deal to cut output, still needs...
You May Also Like
Stuber deals with toxic masculinity, says...
Staggered patrols, meetings, new drills lower...
Jeffrey Epstein spent $350K to ‘influence’...
Ex-pitcher Dwight Gooden charged with drug...
Amazon Prime Day Sale 2019 Offers, Deals:...
Tencent Holdings want a bigger cut of game sales
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version